JNJ may end up getting pretty good value for its 2010 acquisition of Crucell, N.V. — a deal in which JNJ paid $2.4B for the 82% of Crucell it did not already own (#msg-55228522).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.